On Wednesday, Following Stocks were among the “Top 100 Gainers” In U.S. Stock Exchange: Receptos Inc (NASDAQ:RCPT), Pilgrim’s Pride Corporation (NASDAQ:PPC), Zogenix, Inc (NASDAQ:ZGNX), Silvercorp Metals Inc. (USA) (NYSE:SVM)
Receptos Inc (NASDAQ:RCPT)’s shares picked up 5.19%, and closed at $173.44, hitting new 52-week high of $203.55, during the last trading session. The stock has price to sale ratio of 927.46, however, price to book ratio is 7.70. With recent incline, the year-to-date (YTD) performance reflected a 41.57% incline below last year. During the past month the stocks gain 38.76%, bringing three-month performance to 41.78% and six-month performance to 179.25%. The mean recommendation of analysts for this stock is 1.70. (where 1=Buy, 5=Sale).
Receptos, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in immune disorders. Its lead product comprises ozanimod, an oral therapy that is in phase III studies for the treatment of relapsing multiple sclerosis; and is in phase II studies to treat ulcerative colitis and crohn’s disease. The company is also developing RPC4046, a monoclonal antibody, which is in phase II trials for the treatment of eosinophilic esophagitis, an allergic/immune-mediated disorder. In addition, it is involved in a research program for glucagon-like peptide-1 receptor small molecule positive allosteric modulators that is in preclinical studies for the treatment of Type 2 diabetes.
Pilgrim’s Pride Corporation (NASDAQ:PPC), raised 5.16%, and closed at $23.75. The company holds the market capitalization of $5.87B. For the last twelve months, the stock was able to keep return on equity at 37.60%, while return on assets at 22.10%, in response to its return on investment at 36.90%. Its 20-day moving average declined -6.65%, below 50-day moving average of -11.52%, below 200-day moving average of -9.03% from the latest market price of $23.75. The mean recommendation of analysts for this stock is 2.60.(where 1=Buy, 5=Sale).
Pilgrim’s Pride Corporation engages in the production, processing, marketing, and distribution of fresh, frozen, and value-added chicken products to retailers, distributors, and foodservice operators in the United States, Mexico, and Puerto Rico. It offers fresh chicken products comprising pre-marinated or non-marinated, and prepackaged refrigerated (nonfrozen) whole or cut-up chicken in various combinations of refrigerated whole chickens and chicken parts. The company also provides prepared chicken products, such as portion-controlled breast fillets, tenderloins and strips, delicatessen products, salads, formed nuggets and patties, and bone-in chicken parts.
Zogenix, Inc (NASDAQ:ZGNX), enhanced 5.11%, and closed at $1.44. The stock has the beta value of 2.25, and its volatility for the week is 4.38%, while for the month it is 7.07%. The company has the market capitalization of $220.84M. The company holds the book value per share of 0.37, whereas cash per share is 0.28. Price to book ratio remained 3.89, while price to sale ratio is 5.45. Analysts mean recommendation for the stock is said to be 1.40 (where 1=Buy, 5=sale).
Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. Its marketed product comprises Zohydro ER, an extended-release formulation of hydrocodone for the treatment of severe chronic pain. The company also develops ZX008, a low-dose fenfluramine for the treatment of Dravet syndrome; and Relday, an injectable formulation of risperidone that is in Phase Ib clinical trial to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older. It markets and sells its products to physicians, nurses, and other healthcare professionals. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in San Diego, California.
Silvercorp Metals Inc. (USA) (NYSE:SVM), rose 5.08%, and closed at $1.24. The company has the market capitalization of $198.22M. The beta value of the stock is 0.85. On the other hand the stock’s volatility for the week is 6.48%, and for the month is 6.52%. The stock’s price to book ratio is 0.58, however price to sale ratio is 1.72. Analyst’s mean recommendation regarding this stock is 2.50. (where 1=Buy, 5=Sale).
Silvercorp Metals Inc., together with its subsidiaries, is engaged in the attainment, exploration, development, and mining of mineral properties in China and Canada. The company’s principal property comprises the Ying silver-lead-zinc project located in the Ying Mining District, the Henan Province, China. It also explores for gold properties. The company was formerly known as SKN Resources Ltd. and changed its name to Silvercorp Metals Inc. in May 2005. Silvercorp Metals Inc. is headquartered in Vancouver, Canada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
